HYPHENS PHARMA revenue breakdown overview

HYPHENS PHARMA revenue for the last year amounted to 195.42 M SGD, the most of which — 124.25 M SGD — came from its highest performing source at the moment, Specialty Pharma Principals, the year earlier bringing 102.19 M SGD. The greatest contribution to the revenue figure was made by Singapore — last year it brought HYPHENS PHARMA 90.89 M SGD, and the year before that — 85.00 M SGD.